Detalles de la búsqueda
1.
Definition of rheumatoid arthritis flare based on SDAI and CDAI.
Ann Rheum Dis
; 83(2): 169-176, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37890977
2.
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
J Rheumatol
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621792
3.
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.
Ann Rheum Dis
; 82(6): 820-828, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36813538
4.
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
Ann Rheum Dis
; 82(2): 175-181, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100351
5.
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases.
Rheumatology (Oxford)
; 2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37773994
6.
Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.
Rheumatology (Oxford)
; 2023 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738257
7.
Willingness, perceived facilitators and barriers to use remote care among healthcare professionals - a cross-sectional study.
BMC Health Serv Res
; 23(1): 1307, 2023 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012633
8.
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
Ann Rheum Dis
; 81(10): 1358-1366, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35705376
9.
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.
Rheumatology (Oxford)
; 61(9): 3799-3807, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940840
10.
The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission status.
Rheumatology (Oxford)
; 59(11): 3458-3467, 2020 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32375173
11.
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
Rheumatology (Oxford)
; 59(9): 2455-2461, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31960053
12.
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
Rheumatology (Oxford)
; 59(7): 1640-1650, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31665497
13.
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.
Ann Rheum Dis
; 78(11): 1536-1544, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31431486
14.
Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.
Ann Rheum Dis
; 77(9): 1290-1294, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29875096
15.
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration.
Ann Rheum Dis
; 77(9): 1276-1282, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29730637
16.
Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.
Ann Rheum Dis
; 76(11): 1906-1910, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28733473
17.
Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Ann Rheum Dis
; 76(4): 708-711, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27707730
18.
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatment.
Joint Bone Spine
; 91(4): 105729, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38582359
19.
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe.
Lancet Reg Health Eur
; 33: 100706, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601339
20.
No Association Between Risk of Anterior Cruciate Ligament Rupture and Selected Candidate Collagen Gene Variants in Female Elite Athletes From High-Risk Team Sports.
Am J Sports Med
; 47(1): 52-58, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30485117